• Betaine hydrochloride in Inflammation Assays

  2026-09-30

  Betaine hydrochloride provides a water-soluble, tunable matrix variable for enzyme, protease, cell-based, and inflammation-linked assays. This workflow separates what the reagent can control experimentally from the anti-inflammatory activity reported for oridonin, helping researchers build cleaner mechanistic comparisons.

• Cy5-UTP for RNA Labeling and R-Loop Imaging

  2026-09-30

  Cy5-UTP enables direct far-red visualization of RNA generated by T7 transcription, supporting FISH, expression-array, and single-molecule assays. This guide translates its labeling chemistry into practical workflows for studying RNA–DNA hybrids and replication conflicts while highlighting controls, optimization points, and limitations.

• ATRX-Deficient Glioma Sensitivity to RTK Inhibitors

  2026-09-29

  The reference study identifies a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells show increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its drug-screening and temozolomide combination data support ATRX status as a potentially useful stratification variable for interpreting RTK inhibitor studies, while remaining preclinical.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-29

  This 2025 study develops patient-derived gastric cancer assembloids by combining matched tumor organoids with tumor-derived stromal subpopulations. The model reveals that stromal composition reshapes gene expression and drug sensitivity, providing a more physiologically relevant platform for resistance studies and personalized therapeutic screening.

• Trilaurin: Solubility, QC, and Workflow Setup

  2026-09-28

  Trilaurin, also called Glycerol Tridodecanoate, is a defined C12 triacylglycerol for lipid formulation development and enzyme-substrate workflows, with practical solubility options in DMSO and ethanol. It should not be treated as water-soluble or as evidence of biological efficacy; formulation, animal-study, cosmetic, and biocatalytic applications require application-specific validation.

• Fiber Density Rebuilds Annulus Fibrosus Matrix Patterns

  2026-09-28

  This study shows that changing the fiber density of composition-matched electrospun scaffolds can shift annulus fibrosus cells toward distinct collagen-producing phenotypes. Its findings connect scaffold microarchitecture with mechanotransduction and suggest a design strategy for recreating, rather than merely closing, the annulus fibrosus defect.

• Galectin-1–FIP200 Signaling in Hepatic Steatosis

  2026-09-27

  The study identifies a direct interaction between galectin-1 and FIP200 as a mechanism that suppresses autophagy and promotes hepatic steatosis, dyslipidemia, and insulin resistance. Its combination of mouse overexpression, proteomic profiling, binding analysis, and interaction-disrupting mutations provides a framework for testing how autophagy control contributes to metabolic liver disease.

• BTK Inhibition: From Mechanism to Translation

  2026-09-26

  Explore how PCI-32765 enables rigorous BTK pathway studies, from B-cell receptor signaling and CLL models to translationally grounded experimental design.

• α-Bungarotoxin for Cholinergic Blockade Research

  2026-09-25

  Use α-Bungarotoxin to test whether α7 nicotinic receptor signaling is necessary for a cellular or tissue response—not merely associated with it. A recent placental ischemia study illustrates this antagonist-based strategy, while the workflow below adapts it for carefully controlled cell assays and neuroscience research.

• Hepatocyte Arrb2 and 6-ketoLCA in Liver IRI

  2026-09-25

  This study identifies hepatocyte Arrb2 as a regulator of a metabolite-linked interaction between liver cells and macrophages during ischemia–reperfusion injury. Its findings support a protective pathway involving 6-ketoLCA and M2 macrophage polarization, while leaving important questions about the pathway’s molecular details and clinical translation open.

• Lipo3K Transfection Reagent for Viability Assays

  2026-09-24

  Learn how Lipo3K Transfection Reagent (SKU K2705) can support nucleic-acid delivery in viability, proliferation, and cytotoxicity workflows. This scenario-led guide covers assay controls, timing, co-transfection, interpretation, and practical product selection.

• T0070907 and PPARγ: Testing a Foam-Cell Pathway

  2026-09-24

  A mechanistic look at how T0070907 can help translational teams test whether PPARγ activity is required for the RXRα/PPARγ/NEDD4 response reported in atherosclerosis research—without confusing pathway probing with therapeutic proof.

• Tioconazole Workflows for Antifungal Research

  2026-09-23

  Build more interpretable Tioconazole experiments by pairing dose-response testing with solvent-matched controls and an orthogonal viability readout. This guide connects its ergosterol-targeting rationale to practical in vitro workflows while clearly separating antifungal evidence from an unrelated leukemia study used only as a lesson in experimental context.

• Dasatinib Monohydrate and NET Assay Design

  2026-09-23

  Dasatinib Monohydrate research can extend beyond kinase inhibition into CML-associated neutrophil extracellular trap biology. This article connects BMS-354825 pharmacology with NET assay design, resistance modeling, and evidence-based interpretation of vascular inflammation endpoints.

• KR-12 Charge Placement and Membrane Activity

  2026-09-22

  The reference study shows that KR-12 activity depends not only on total cationic charge but also on where each basic residue sits within its amphipathic helix. Alanine scanning and membrane assays identify distinct roles for interfacial and helix-face residues, providing a framework for rational engineering of LL-37-derived antimicrobial peptides.

7670 records 1/512 page Next 12345 下5页 Last page